Author

S. J. A. Buczacki

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:ATAC-seq· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Research Focus:host-pathogen & immune response· 1 Assay:scRNA-seq· 1

Frequent Co-Authors

A. J. Butler· 1 shared A. M. Moon· 1 shared A. Mandal· 1 shared A. P. Davenport· 1 shared A. Simmons· 1 shared A. W. Lohse· 1 shared C. J. E. Watson· 1 shared D. Fawkner-Corbett· 1 shared

Activity by Year

2021-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. J. Butler

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintAug 25, 2023

Mutational order and epistasis determine the consequences of FBXW7 mutations during colorectal cancer evolution

D. K. H. Chan, A. Mandal, Y. Zhou…·S. J. A. Buczacki

This study shows that the order of FBXW7 and APC mutations affects colorectal cancer initiation, with FBXW7 mutations before APC preventing cancer-like features.

DOI 10.1101/2023.08.25.554836

humanscRNA-seq

𝕏 PostBluesky

MicrobiologybioRxivPreprintJun 6, 2021

FXR inhibition reduces ACE2 expression, SARS-CoV-2 infection and may improve COVID-19 outcome

T. Brevini, M. Maes, G. J. Webb…·F. Sampaziotis

This study shows FXR inhibition lowers ACE2 expression, reduces SARS-CoV-2 infection, and correlates with better clinical outcomes in COVID-19.

DOI 10.1101/2021.06.06.446781

humanexperimental assay

𝕏 PostBluesky